82 related articles for article (PubMed ID: 3089021)
1. Characterization of renal amyloid derived from the variable region of the lambda light chain subgroup II.
Picken MM; Gallo G; Buxbaum J; Frangione B
Am J Pathol; 1986 Jul; 124(1):82-7. PubMed ID: 3089021
[TBL] [Abstract][Full Text] [Related]
2. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).
Husby G; Sletten K; Blumenkrantz N; Danielsen L
Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317
[TBL] [Abstract][Full Text] [Related]
3. Amyloid fibrils derived from V-region together with C-region fragments from a lambda II-immunoglobulin light chain (HAR).
Eulitz M; Linke R
Biol Chem Hoppe Seyler; 1985 Sep; 366(9):907-15. PubMed ID: 3935132
[TBL] [Abstract][Full Text] [Related]
4. AH amyloidosis associated with an immunoglobulin heavy chain variable region (VH1) fragment: a case report.
Miyazaki D; Yazaki M; Gono T; Kametani F; Tsuchiya A; Matsuda M; Takenaka Y; Hosh Y; Ikeda S
Amyloid; 2008 Jun; 15(2):125-8. PubMed ID: 18484339
[TBL] [Abstract][Full Text] [Related]
5. The importance of the light chain for the epitope specificity of human anti-U1 small nuclear RNA autoantibodies present in systemic lupus erythematosus patients.
Hoet RM; Pieffers M; Stassen MH; Raats J; de Wildt R; Pruijn GJ; van den Hoogen F; van Venrooij WJ
J Immunol; 1999 Sep; 163(6):3304-12. PubMed ID: 10477600
[TBL] [Abstract][Full Text] [Related]
6. The precursor molecule of a V lambda II-immunoglobulin light chain-derived amyloid fibril protein circulates precleaved.
Eulitz M; Linke RP
Biochem Biophys Res Commun; 1993 Aug; 194(3):1427-34. PubMed ID: 8352801
[TBL] [Abstract][Full Text] [Related]
7. Primary structure of the variable region of a human lambda VI light chain: Bence Jones protein SUT.
Frangione B; Moloshok T; Solomon A
J Immunol; 1983 Nov; 131(5):2490-3. PubMed ID: 6415173
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of immunoglobulin light chain amyloidosis with antibodies to the immunoglobulin light chain variable region.
Hoshii Y; Kiyama M; Cui D; Kawano H; Ishihara T
Pathol Int; 2006 Jun; 56(6):324-30. PubMed ID: 16704496
[TBL] [Abstract][Full Text] [Related]
9. Amyloid fibril protein related to immunoglobulin lambda-chains.
Skinner M; Benson MD; Cohen AS
J Immunol; 1975 Apr; 114(4):1433-5. PubMed ID: 804011
[TBL] [Abstract][Full Text] [Related]
10. Characterization of amyloid deposits and P component from a patient with factor X deficiency reveals proteins derived from a lambda VI light chain.
Cohen D; Pras M; Franklin EC; Frangione B
Am J Med; 1983 Mar; 74(3):513-8. PubMed ID: 6402931
[TBL] [Abstract][Full Text] [Related]
11. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
Harris DL; King E; Ramsland PA; Edmundson AB
J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
[TBL] [Abstract][Full Text] [Related]
12. Demonstration and partial characterization of an atypical protein in the urine of a patient with primary amyloidosis.
Wille LE; Olsen E; Førre O; Sletten K; Jentoft H
Acta Med Scand; 1980; 208(3):177-82. PubMed ID: 6776783
[TBL] [Abstract][Full Text] [Related]
13. Nodular glomerulopathy associated with nonamyloidotic kappa light chain deposits and excess immunoglobulin light chain synthesis.
Gallo GR; Feiner HD; Katz LA; Feldman GM; Correa EB; Chuba JV; Buxbaum JN
Am J Pathol; 1980 Jun; 99(3):621-44. PubMed ID: 6770693
[TBL] [Abstract][Full Text] [Related]
14. Influence of tissue fixation on the microextraction and identification of amyloid proteins.
Röcken C; Wilhelm S
J Lab Clin Med; 2005 Oct; 146(4):244-50. PubMed ID: 16194686
[TBL] [Abstract][Full Text] [Related]
15. Amyloid fibril protein of light chain type from the muscle in a patient with amyloidosis.
Isobe T; Imura H; Miyazaki K
Nihon Ketsueki Gakkai Zasshi; 1976 Jun; 39(3):329-30. PubMed ID: 824926
[No Abstract] [Full Text] [Related]
16. Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain.
Kiyama M; Hoshii Y; Cui D; Kawano H; Kanda T; Ishihara T
Pathol Int; 2007 Jun; 57(6):343-50. PubMed ID: 17539965
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin synthesis in primary and myeloma amyloidosis.
Preud'homme JL; Ganeval D; Grünfeld JP; Striker L; Brouet JC
Clin Exp Immunol; 1988 Sep; 73(3):389-94. PubMed ID: 3145161
[TBL] [Abstract][Full Text] [Related]
18. AL 612, a glycosylated lambda light chain of subgroup I.
Nilsen T; Sletten K; Westermark P
Amyloid; 2000 Mar; 7(1):51-3. PubMed ID: 10842706
[No Abstract] [Full Text] [Related]
19. Chemical and serologic characterization of human lambda VIII light chains.
Solomon A; Weiss DT; Murphy C; Fu SM; Robbins DL
J Immunol; 1994 Aug; 153(4):1658-64. PubMed ID: 8046238
[TBL] [Abstract][Full Text] [Related]
20. Lambda II immunoglobulin light chain protein in primary localized rectal amyloidosis.
Zaky ZS; Liepnieks JJ; Rex DK; Cummings OW; Benson MD
Amyloid; 2007 Dec; 14(4):299-304. PubMed ID: 17968691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
